Clinical Trial Update: Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide [Phase 1]

View source ↗

Summary

A Phase 1 dose-finding study of oral eltrombopag in sarcoma patients receiving Adriamycin and ifosfamide, focusing on thrombocytopenia; the trial status is COMP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma
• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thrombocytopaenia | Phase 1 | Status: COMPLETED